Regeneron Pharmaceuticals Inc (REGN)
804.33
-16.67
(-2.03%)
USD |
NASDAQ |
Nov 13, 16:00
804.00
-0.33
(-0.04%)
After-Hours: 20:00
Regeneron Pharmaceuticals Long Term Cap Lease Obligation (Quarterly)
Long Term Cap Lease Obligation (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Long Term Cap Lease Obligation (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| Date | Value |
|---|---|
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
Long Term Capital Lease Obligation Definition
Long Term Capital Lease Obligation is the amount due for asset lease agreements that are due in more than one year from balance sheet date. These are liabilities in the balance sheet.
Long Term Cap Lease Obligation (Quarterly) Range, Past 5 Years
Long Term Cap Lease Obligation (Quarterly) Benchmarks
| Amgen Inc | -- |
| Eli Lilly and Co | -- |
| Pfizer Inc | -- |
| AbbVie Inc | -- |
| Biogen Inc | Upgrade |